DA
XYL icon

Dunvegan Associates’s Xylem XYL Stock Holding History

Dunvegan Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$39K Hold
1,065
– – 0.05% 109
2015
Q3 		$35K Hold
1,065
– – 0.04% 111
2015
Q2 		$39K Hold
1,065
– – 0.04% 111
2015
Q1 		$37K Hold
1,065
– – 0.03% 126
2014
Q4 		$41K Hold
1,065
– – 0.04% 118
2014
Q3 		$38K Buy
1,065
+300
+39% +$11.1K 0.03% 116
2014
Q2 		$30K Hold
765
– – 0.03% 126
2014
Q1 		$28K Buy
+765
New +$27.9K 0.02% 131

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dunvegan Associates's XYL Position: Q4 2015 in Review

Dunvegan Associates held its Xylem (XYL) position steady in Q4 2015 at 1,065 shares worth $39K. The position accounts for 0.05% of the portfolio, ranked #109.

Dunvegan Associates first reported a position in XYL in Q1 2014 and has held it in 8 quarters since. The position peaked at $41K in Q4 2014. 443 funds tracked by Wall St. Rank hold XYL as of Q4 2015.

  • Dunvegan Associates held 1,065 shares of Xylem worth $39K as of Q4 2015.
  • Dunvegan Associates left its Xylem share count unchanged in Q4 2015.
  • Xylem made up 0.05% of Dunvegan Associates's portfolio in Q4 2015, its #109 holding.
  • Dunvegan Associates first reported a position in Xylem in Q1 2014 and has held it in 8 quarters since.
  • Dunvegan Associates's Xylem position peaked at $41K in Q4 2014.
  • 443 funds tracked by Wall St. Rank held Xylem as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.